The 2026 António Champalimaud Prize was awarded to researchers Botond Roska and José-Alain Sahel for their innovative work in vision restoration. The Champalimaud Foundation announced this distinction today, recognizing the scientific and humanitarian relevance of the research conducted by these two specialists.
The winning research enabled people with visual impairment or blindness caused by retinal diseases to regain their vision. This advance represents a significant milestone in the field of ophthalmology and neuroscience, offering hope to millions of people affected by degenerative retinal pathologies.
Botond Roska and José-Alain Sahel are internationally recognized for their pioneering work at the interface of biotechnology and ocular medicine. The collaboration between these researchers resulted in the development of therapies that use innovative approaches to restore visual function in patients who previously had no other treatment options available.



